{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:49Z","timestamp":1761514129761,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"GlaxoSmithKline Korea"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.seizure.2017.12.008","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T22:00:01Z","timestamp":1514498401000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy"],"prefix":"10.1016","volume":"55","author":[{"given":"Byung In","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Kee","family":"No","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Doe","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyang Woon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ok Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Moon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Pa","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong In","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Je","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.12.008_bib0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2017.12.008_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/awh726","article-title":"Natural history of treated child-onset epilepsy: prospective, long-term population-based study","volume":"129","author":"Sillanp\u00e4\u00e4","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2017.12.008_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/01.wnl.0000286959.22040.6e","article-title":"Quantifying the response to antiepileptic drugs: effect of past treatment history","volume":"70","author":"Schiller","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.008_bib0020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutics Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.yebeh.2007.02.011","article-title":"How reliable is early treatment response in predicting long-term seizure outcome","volume":"10","author":"Schmidt","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.12.008_bib0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"for the ILAE subcommission on AED guideline Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00023210-200216030-00002","article-title":"Place of polytherapy in the early treatment of epilepsy","volume":"16","author":"Deckers","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2017.12.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2003.09.007","article-title":"Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicenter, randomized, pragmatic controlled trial","volume":"57","author":"Beghi","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.008_bib0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails: substitution or add-on","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2017.12.008_bib0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1734-1140(11)70497-2","article-title":"Basic mechanisms of antiepileptic drugs and their pharmacokinetic\/pharmacodynamic interactions: an update","volume":"63","author":"Lason","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.seizure.2017.12.008_bib0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"For 105 Group Study: lamotrigine substitution study: evidence for synergism with sodium valproate","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.008_bib0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archneur.1983.04050120047006","article-title":"Valproate-ethosuximide combination therapy for absence seizures","volume":"40","author":"Rowan","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2017.12.008_bib0065","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(05)60613-7","article-title":"Lamotrigine and topiramate may be a useful combination","volume":"351","author":"Stephen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2017.12.008_bib0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2165\/11587550-000000000-00000","article-title":"A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs","volume":"24","author":"Sake","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2017.12.008_bib0075","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1157.1999.tb00832.x","article-title":"The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a phramcodynamic interaction","volume":"40","author":"Pisani","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.55.4.588","article-title":"Adding valproate to lamotrigine: a study of their pharmacokinetic interaction","volume":"54","author":"Kanner","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.008_bib0085","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archneur.58.8.1264","article-title":"Effect of divalproex-lamotrigine combination therapy in frontal lobe epilepsy","volume":"58","author":"McCabe","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2017.12.008_bib0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1528-1167.2008.01866.x","article-title":"Lamotrigine-valproic acid combination therapy for medically refractory epilepsy","volume":"50","author":"Moeller","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.0b013e31823ed0dd","article-title":"Comparative efficacy of combination drug therapy in refractory epilepsy","volume":"78","author":"Poolos","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.008_bib0100","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1046\/j.1528-1157.2001.30800.x","article-title":"Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study","volume":"42","author":"Deckers","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsy and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"ILAE Commission on Antiepileptic Drugs. Consideration on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0125","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1528-1157.1999.tb00831.x","article-title":"Adding lamotrigine to valproate: incidence of rash and other adverse effects","volume":"40","author":"Faught","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0140-6736(93)91398-6","article-title":"Disabling tremor after lamotrigine with sodium valproate","volume":"342","author":"Reutens","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2017.12.008_bib0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clnically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2017.12.008_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.09.008","article-title":"Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy","volume":"57","author":"Gidal","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.008_bib0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1528-1157.1995.tb00484.x","article-title":"Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment","volume":"36","author":"Lammers","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2011.09.008","article-title":"Antiepileptic drug combinations-have newer agents altered clinical outcomes","volume":"98","author":"Stephen","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.008_bib0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.1980.tb04328.x","article-title":"Once daily sodium valproate in the treatment of epilepsy","volume":"22","author":"Covanis","year":"1980","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2017.12.008_bib0160","first-page":"527","article-title":"Dosing frequency and medication adherence in chronic disease","volume":"18","author":"Coleman","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.seizure.2017.12.008_bib0165","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1212\/01.wnl.0000277698.33743.8b","article-title":"Lamotrigine extended-release as adjunctive therapy for partial seizures","volume":"69","author":"Naritoku","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.008_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformations risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2017.12.008_bib0175","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2017.12.008_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b2f8","article-title":"Practice parameter update: management issues for women with epilepsy\u2013focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.008_bib0185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.008_bib0190","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","article-title":"Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study","volume":"85","author":"Tomson","year":"2015","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117306970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117306970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:35Z","timestamp":1761011375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117306970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"alternative-id":["S1059131117306970"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.12.008","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}